HMGB1 and infectious disease: Many studies have reported that HMGB1, as an important late-stage inflammatory mediator, is an important therapeutic target for infectious diseases such as sepsis-associated encephalopathy and autoimmune encephalomyelitis (Uzawa et al., 2013) at an early stage.